Pandemic demand creates growth opportunity for domestic vaccine companies
Variants, boosters turn rich-poor vaccine gap into chasm
2 December 2021Study reports a novel broad-spectrum antiviral drug class with activity against SARS-CoV-2
2 December 2021Pandemic demand creates growth opportunity for domestic vaccine companies
Any pandemic sends shockwaves through markets, forcing companies to adapt to surging demand. New University of Minnesota research highlights the differences in how domestic and foreign firms reacted amid the 2009-10 H1N1 pandemic, offering insights that resonate today during the current global supply chain troubles amid the COVID-19 pandemic.
